Trends with corticosteroid use in males with Duchenne muscular dystrophy born 1982-2001
- PMID: 24682290
- DOI: 10.1177/0883073813517263
Trends with corticosteroid use in males with Duchenne muscular dystrophy born 1982-2001
Abstract
This study examines trends in corticosteroid use for males with Duchenne muscular dystrophy by birth year, race/ethnicity, and knowledge of Duchenne muscular dystrophy family history. Firstborn males (n = 521) selected from a population-based surveillance system of Duchenne muscular dystrophy were analyzed using Kaplan Meier and regression methods. Comparing males born 1982 to 1986 with males born 1997 to 2001, steroid use increased from 54% to 72% and mean age at steroid initiation decreased from 8.2 to 7.1 years. Hispanics and non-Hispanic Black males used steroids less frequently and delayed initiation compared to white males. Compared to males without a Duchenne muscular dystrophy family history, males with known family history were half as likely to use steroids. Duration of steroid use increased over time and age at initiation decreased. Racial/ethnic disparities exist for steroid use and should be addressed to improve outcome and quality of life for boys with Duchenne muscular dystrophy.
Keywords: Duchenne muscular dystrophy; age of treatment initiation; health disparities; length of use; steroids.
© The Author(s) 2014.
Similar articles
-
Racial and Ethnic Differences in Timing of Diagnosis and Clinical Services Received in Duchenne Muscular Dystrophy.Neuroepidemiology. 2023;57(2):90-99. doi: 10.1159/000528962. Epub 2023 Jan 9. Neuroepidemiology. 2023. PMID: 36623491 Free PMC article.
-
The effect of steroid treatment on weight in nonambulatory males with Duchenne muscular dystrophy.Am J Med Genet A. 2018 Nov;176(11):2350-2358. doi: 10.1002/ajmg.a.40517. Epub 2018 Sep 26. Am J Med Genet A. 2018. PMID: 30256515 Free PMC article.
-
Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy.Neuromuscul Disord. 2017 Aug;27(8):730-737. doi: 10.1016/j.nmd.2017.05.019. Epub 2017 Jun 5. Neuromuscul Disord. 2017. PMID: 28645460 Free PMC article.
-
Glucocorticoid corticosteroids for Duchenne muscular dystrophy.Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003725. doi: 10.1002/14651858.CD003725.pub3. Cochrane Database Syst Rev. 2008. Update in: Cochrane Database Syst Rev. 2016 May 05;(5):CD003725. doi: 10.1002/14651858.CD003725.pub4 PMID: 18254031 Updated. Review.
-
Glucocorticoid corticosteroids for Duchenne muscular dystrophy.Cochrane Database Syst Rev. 2004;(2):CD003725. doi: 10.1002/14651858.CD003725.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003725. doi: 10.1002/14651858.CD003725.pub3 PMID: 15106215 Updated. Review.
Cited by
-
Mechanisms of Chimeric Cell Therapy in Duchenne Muscular Dystrophy.Biomedicines. 2024 Sep 2;12(9):1996. doi: 10.3390/biomedicines12091996. Biomedicines. 2024. PMID: 39335509 Free PMC article.
-
Subspecialty Health Care Utilization in Pediatric Patients With Muscular Dystrophy in the United States.Neurol Clin Pract. 2024 Aug;14(4):e200312. doi: 10.1212/CPJ.0000000000200312. Epub 2024 May 31. Neurol Clin Pract. 2024. PMID: 38855715
-
Racial and Ethnic Differences in Timing of Diagnosis and Clinical Services Received in Duchenne Muscular Dystrophy.Neuroepidemiology. 2023;57(2):90-99. doi: 10.1159/000528962. Epub 2023 Jan 9. Neuroepidemiology. 2023. PMID: 36623491 Free PMC article.
-
Selected clinical and demographic factors and all-cause mortality among individuals with Duchenne muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking, and Research Network.Neuromuscul Disord. 2022 Jun;32(6):468-476. doi: 10.1016/j.nmd.2022.04.008. Epub 2022 Apr 30. Neuromuscul Disord. 2022. PMID: 35597713 Free PMC article.
-
Association of genetic mutations and loss of ambulation in childhood-onset dystrophinopathy.Muscle Nerve. 2021 Feb;63(2):181-191. doi: 10.1002/mus.27113. Epub 2020 Nov 17. Muscle Nerve. 2021. PMID: 33150975 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

